COVID-19 vaccination in adolescents and young adults with type 1 diabetes: Glycemic control and side effects.

ABSTRACT:

Background

Two vaccines against SARS-CoV-2 are approved by the World Health Organization (WHO) for minors aged 12 years and over. Currently, people with both type 1 diabetes (T1D) and type 2 diabetes (T2D) are prioritized for vaccination.

Objective

To evaluate possible glycemic control modification, insulin dose adjustment and adverse effects after COVID-19 vaccination in young T1D individuals, users of different technology levels.

Methods

Thirty-nine T1D individuals, who received a whole vaccination cycle of either Moderna or Pfizer- BioNTech vaccines, were enrolled, 24 of whom using advanced hybrid closed loop systems (AHCLs) and 15 using intermittently scanned continuous glucose monitoring (isCGM). Symptoms after each dose and the following variables were considere

SUBMITTER: Piccini B 

PROVIDER: S-EPMC9115347 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature